Potential Polymorphic CYP1A2 and CYP2D6-mediated Pharmacokinetic Interactions between Risperidone or Olanzapine and Selected Drugs Intended to Treat COVID-19

Ariana Rojas-Macetas, Geraldine Medalla-Garro, María Saravia, Ricardo Losno, Milton Valderrama-Wong, Ricardo Pariona, Angel Tito Alvarado Yarasca*

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Potential Polymorphic CYP1A2 and CYP2D6-mediated Pharmacokinetic Interactions between Risperidone or Olanzapine and Selected Drugs Intended to Treat COVID-19'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science